1) topoisomerase Ⅱα
拓朴异构酶Ⅱα
1.
Detection of human telomerase reverse transcriptase,p53,topoisomerase Ⅱα,hormone receptors and apoptosis and their correlation in endometrial adenocarcinoma;
子宫内膜癌中端粒酶逆转录酶与p53、拓朴异构酶Ⅱα、激素受体、凋亡小体的检测及相关性
2) topoisomeraseⅡα
拓扑异构酶Ⅱα
1.
Amplification of TopoisomeraseⅡα and c-myc Gene in Breast Cancer and Its Correlation with Neoadjuvant Chemotherapy Response;
[背景]新辅助化疗已成为局部晚期乳腺癌的标准初始治疗方案，新辅助化疗的疗效是病人长期生存率的重要预后标志，以往的研究提示拓扑异构酶Ⅱα基因(TOPO Ⅱα)可能与蒽环类为主的新辅助化疗疗效相关，可用作预测化疗敏感性的标志。
3) Topoisomerase Ⅱα
拓扑异构酶Ⅱα
1.
Expression of Topoisomerase Ⅱα in Nasopharyngeal Carcinoma and Its Clinical Significance;
鼻咽癌组织拓扑异构酶Ⅱα的表达及其临床意义
2.
Objective To investigate the expression and clinical significance of Topoisomerase Ⅱαprotein in hepatocellular carcinoma(HCC) tissues and its relationship with p53 gene mutation.
目的研究原发性肝癌拓扑异构酶Ⅱα(Topoisom eraseⅡ,αToPoⅡα)的表达及临床意义,并探讨其与p53基因突变之间的关系。
3.
Objective To investigate the expression of topoisomerase Ⅱα (Topo Ⅱα) and its relationship with Ki67 protein, p53 gene in nonsmall cell lung carcinoma (NSCLC).
目的 研究非小细胞肺癌患者拓扑异构酶Ⅱα (TopoisomeraseⅡα ,TopoⅡα)的表达 ,并探讨其与Ki6 7蛋白、p5 3基因的关系。
4) TopoⅡα
拓扑异构酶Ⅱα
1.
Methods: The expressions of TopoⅡα,GST-π,P-gp in 80 cases of ovarian carcinoma,20 cases of benign ovarian tumor,and 20 cases of normal control were determined by using SP immunohistochemistry and image analysis system.
目的:研究卵巢癌中拓扑异构酶Ⅱα(topoisomeraseα,TopoⅡα)、谷胱甘肽S转移酶π(glutathioneStranserasesπ,GSTπ)、P糖蛋白(Pglycoproein,Pgp)的表达与化疗反应性及预后的关系。
5) Topo Ⅱα
拓扑异构酶Ⅱα
1.
Expression of Topo Ⅱα and Ki-67 in Human Hepatocellular Carcinoma and Its Significance;
拓扑异构酶Ⅱα与Ki-67在肝细胞癌中的表达及意义
6) topoisomerase Ⅱ alpha
NA拓扑异构酶Ⅱα
补充资料：拓朴替康
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条